How would you define the success of Clarivate Analytics's Cortellis drug pipeline intelligence service?

Introduction

Defining the success of Clarivate Analytics's Cortellis drug pipeline intelligence service requires a comprehensive approach that considers multiple stakeholders and metrics. To address this product success metrics challenge, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Cortellis is a comprehensive drug pipeline intelligence service provided by Clarivate Analytics. It offers real-time data, analytics, and insights on drug development pipelines, clinical trials, and regulatory information to pharmaceutical companies, researchers, and investors.

Key stakeholders include:

1. Pharmaceutical companies: Seeking competitive intelligence and potential partnership opportunities
2. Researchers: Looking for up-to-date information on drug development trends
3. Investors: Analyzing market potential and investment opportunities
4. Regulatory bodies: Monitoring drug development landscape

User flow:

1. Login to the Cortellis platform
2. Search for specific drugs, companies, or therapeutic areas
3. Access detailed reports, analytics, and visualizations
4. Export data or generate custom reports as needed

Cortellis fits into Clarivate's broader strategy of providing high-value, data-driven insights to life sciences and healthcare industries. It complements other Clarivate offerings like Web of Science and Derwent Innovation.

Competitors include IBM Watson for Drug Discovery and Evaluate Pharma. Cortellis differentiates itself through its comprehensive coverage and advanced analytics capabilities.

Product Lifecycle Stage: Mature - Cortellis has been in the market for several years and is continuously evolving to meet changing industry needs.

Software-specific context:

• Platform: Cloud-based SaaS solution
• Integration points: APIs for integration with client systems
• Deployment model: Web-based access with mobile apps for on-the-go use